Related Experiment Video
Updated: Aug 6, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and
Andrea Alegre-Martí1,2, Alba Jiménez-Panizo1,2, Adrián Martínez-Tébar3
1Structural Biology of Nuclear Receptors, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB), 08028 Barcelona, Spain.
Abstract:
Mutations of the androgen receptor (AR) associated with prostate cancer and androgen insensitivity syndrome may profoundly influence its structure, protein interaction network, and binding to chromatin, resulting in altered transcription signatures and drug responses. Current structural information fails to explain the effect of pathological mutations on AR structure-function relationship. Here, we have thoroughly studied the effects of selected mutations that span the complete dimer interface of AR ligand-binding domain (AR-LBD) using x-ray crystallography in combination with in vitro, in silico, and cell-based assays. We show that these variants alter AR-dependent transcription and responses to anti-androgens by inducing a previously undescribed allosteric switch in the AR-LBD that increases exposure of a major methylation target, Arg761. We also corroborate the relevance of residues Arg761 and Tyr764 for AR dimerization and function. Together, our results reveal allosteric coupling of AR dimerization and posttranslational modifications as a disease mechanism with implications for precision medicine.
Insights
Prostate cancer mutations in the androgen receptor (AR) alter its function. A newly found allosteric switch in the AR ligand-binding domain (AR-LBD) affects transcription and anti-androgen response, offering new precision medicine avenues.
Area of Science:
- Molecular biology
- Structural biology
- Genetics
Background:
- Androgen receptor (AR) mutations are linked to prostate cancer and androgen insensitivity syndrome.
- Existing structural data do not fully explain how mutations impact AR function.
- Understanding AR structure-function relationships is crucial for targeted therapies.
Purpose of the Study:
- To investigate the structural and functional consequences of AR mutations at the ligand-binding domain dimer interface.
- To elucidate the mechanism by which these mutations affect AR-dependent transcription and drug response.
Main Methods:
- X-ray crystallography
- In vitro biochemical assays
- In silico modeling
- Cell-based functional assays
Main Results:
- Selected AR mutations alter AR-dependent transcription and response to anti-androgens.
- These variants induce a novel allosteric switch in the AR ligand-binding domain (AR-LBD).
- The allosteric switch increases exposure of Arg761, a key methylation site, and highlights the roles of Arg761 and Tyr764 in AR dimerization and function.
Conclusions:
- Allosteric coupling between AR dimerization and post-translational modifications represents a disease mechanism.
- Findings have implications for developing precision medicine strategies for prostate cancer.
- Targeting AR allosteric regulation could offer new therapeutic approaches.
More Related Videos
10:12Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Tyrosine Kinases
Internal Receptors
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...